These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11941331)

  • 21. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of budesonide inhalation suspension in the treatment of pediatric asthma.
    Szefler SJ
    Pharmacotherapy; 2001 Feb; 21(2):195-206. PubMed ID: 11213857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety profile of budesonide inhalation suspension in the pediatric population: worldwide experience.
    Szefler SJ; Lyzell E; Fitzpatrick S; Cruz-Rivera M
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):83-90. PubMed ID: 15281476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications.
    McLaughlin T; Leibman C; Patel P; Camargo CA
    Curr Med Res Opin; 2007 Jun; 23(6):1319-28. PubMed ID: 17559731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Budesonide inhalation suspension for the treatment of asthma in infants and children.
    Berger WE
    Drugs; 2005; 65(14):1973-89. PubMed ID: 16162021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of inhaled corticosteroids for persistent asthma in infants and young children.
    Berger WE; Shapiro GG
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):387-399; quiz 399-402, 463. PubMed ID: 15104189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid.
    Szefler SJ
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):175-83. PubMed ID: 10518844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate.
    Nicolini G; Cremonesi G; Melani AS
    Pulm Pharmacol Ther; 2010 Jun; 23(3):145-55. PubMed ID: 19961948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma.
    Skoner DP; Szefler SJ; Welch M; Walton-Bowen K; Cruz-Rivera M; Smith JA
    J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):259-68. PubMed ID: 10669845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of budesonide in inhaled corticosteroid-naive patients and patients with mild persistent asthma.
    Eigen H
    Clin Ther; 2002 Jul; 24(7):1035-48. PubMed ID: 12182250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of budesonide inhalation suspension in children with asthma.
    West KM; Culhane NS
    Ann Pharmacother; 2002 Feb; 36(2):322-5. PubMed ID: 11847955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study designs and challenges in clinical studies conducted in infants and children with asthma.
    Kemp JP
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):184-90. PubMed ID: 10518845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) is effective and safe in adults previously treated with inhaled corticosteroids.
    Metzger WJ; Hampel FC; Sugar M
    J Asthma; 2002 Feb; 39(1):65-75. PubMed ID: 11883741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma.
    Tinkelman DG; Bronsky EA; Gross G; Schoenwetter WF; Spector SL
    J Asthma; 2003 May; 40(3):225-36. PubMed ID: 12807165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of budesonide administered by pressurized metered-dose inhaler in children with asthma.
    Meltzer EO; Pearlman DS; Eckerwall G; Uryniak T; DePietro M; Lampl K
    Ann Allergy Asthma Immunol; 2015 Dec; 115(6):516-22. PubMed ID: 26460293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma.
    Leflein JG; Gawchik SM; Galant SP; Lyzell E; Young M; Cruz-Rivera M; Walton-Bowen K; Smith JA; Fitzpatrick S
    Allergy Asthma Proc; 2001; 22(6):359-66. PubMed ID: 11775393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twice-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.
    Mendelson L; Cook D; Cruz-Rivera M; Fitzpatrick S; Smith JA
    J Asthma; 2002 May; 39(3):227-37. PubMed ID: 12043854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the efficacy and safety of nebulized beclometasone dipropionate and budesonide in severe persistent childhood asthma.
    Delacourt C; Dutau G; Lefrançois G; Clerson P;
    Respir Med; 2003 Feb; 97 Suppl B():S27-33. PubMed ID: 12593525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of budesonide as maintenance therapy for children with asthma.
    Szefler S; Pedersen S
    Pediatr Pulmonol; 2003 Jul; 36(1):13-21. PubMed ID: 12772218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.